Because Pten is often deleted or inactivated in many human cancers, including glioblastoma [24], endometrial carcinoma [25], and lymphoid malignancies [26], we decided to test whether Pten also functions as a tumor suppressor in survival of LSCs and CML development. The gene discussed is PTEN; the disease is neoplasm.